Evidence map›Paper›PMID 32599617›Full record

ArticleBriefings in bioinformatics2021

DeepVF: a deep learning-based hybrid framework for identifying virulence factors using the stacking strategy.

Ruopeng Xie, Jiahui Li, Jiawei Wang, Wei Dai, André Leier, Tatiana T Marquez-Lago, Tatsuya Akutsu, Trevor Lithgow, Jiangning Song, Yanju Zhang

Open access · bronzeAbstract read
In one paragraph

Article in Briefings in bioinformatics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 84 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 6 countries.

Ruopeng XieBioinformatics Lab at Guilin University of Electronic Technology.
Jiahui LiBioinformatics Lab at Guilin University of Electronic Technology.
Jiawei WangBiomedicine Discovery Institute and the Department of Microbiology at Monash University, Australia.
Wei DaiSchool of Computer Science and Information Security, Guilin University of Electronic Technology, China.
André LeierDepartment of Genetics and the Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham (UAB) School of Medicine, USA.
Tatiana T Marquez-LagoDepartment of Genetics and the Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham (UAB) School of Medicine, USA.
Tatsuya AkutsuUniversity of Tokyo, Japan.
Trevor LithgowBiomedicine Discovery Institute and the Director of the Centre to Impact AMR at Monash University, Australia.
Jiangning SongGroup Leader in the Biomedicine Discovery Institute and the Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Australia.ORCID 0000-0001-8031-9086
Yanju ZhangLeiden Institute of Advanced Computer Science, Leiden University.ORCID 0000-0002-8629-258X
Australian Regenerative Medicine Institute · AUGuilin University of Electronic Technology · CNUniversity of Alabama at Birmingham · USLeiden University · NLThe University of Tokyo · JP

Funding

New Tricks for 'Old' Drugs: PK/PD of Polymyxin Nonantibiotic CombinationsR01AI111965 · NIAID · MONASH UNIVERSITY · PI LI, JIAN · 2014 to 2018
$4.3M
NIAID NIH HHS R01 AI111965
6 · The paper itself

Abstract

Virulence factors (VFs) enable pathogens to infect their hosts. A wealth of individual, disease-focused studies has identified a wide variety of VFs, and the growing mass of bacterial genome sequence data provides an opportunity for computational methods aimed at predicting VFs. Despite their attractive advantages and performance improvements, the existing methods have some limitations and drawbacks. Firstly, as the characteristics and mechanisms of VFs are continually evolving with the emergence of antibiotic resistance, it is more and more difficult to identify novel VFs using existing tools that were previously developed based on the outdated data sets; secondly, few systematic feature engineering efforts have been made to examine the utility of different types of features for model performances, as the majority of tools only focused on extracting very few types of features. By addressing the aforementioned issues, the accuracy of VF predictors can likely be significantly improved. This, in turn, would be particularly useful in the context of genome wide predictions of VFs. In this work, we present a deep learning (DL)-based hybrid framework (termed DeepVF) that is utilizing the stacking strategy to achieve more accurate identification of VFs. Using an enlarged, up-to-date dataset, DeepVF comprehensively explores a wide range of heterogeneous features with popular machine learning algorithms. Specifically, four classical algorithms, including random forest, support vector machines, extreme gradient boosting and multilayer perceptron, and three DL algorithms, including convolutional neural networks, long short-term memory networks and deep neural networks are employed to train 62 baseline models using these features. In order to integrate their individual strengths, DeepVF effectively combines these baseline models to construct the final meta model using the stacking strategy. Extensive benchmarking experiments demonstrate the effectiveness of DeepVF: it achieves a more accurate and stable performance compared with baseline models on the benchmark dataset and clearly outperforms state-of-the-art VF predictors on the independent test. Using the proposed hybrid ensemble model, a user-friendly online predictor of DeepVF (http://deepvf.erc.monash.edu/) is implemented. Furthermore, its utility, from the user's viewpoint, is compared with that of existing toolkits. We believe that DeepVF will be exploited as a useful tool for screening and identifying potential VFs from protein-coding gene sequences in bacterial genomes.

Indexed as

BacteriaDatabases, ProteinDeep LearningGenome, BacterialBacterial ProteinsVirulence FactorsBacterial ProteinsVirulence Factorsdeep learningensemble learningmachine learningrecognitionsequence analysisvirulence factor prediction

Identifiers

PMID32599617
PMCPMC8138837
OpenAlexW3039241573

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.